Home

Reporting, Metrics & Accountability

Our patient recruitment strategies are backed by hundreds of programs, reporting and metrics. Read more...

The Leaders in Global Patient Recruitment

Only CSSi is the authority on global patient recruitment. Across all demographics, and all therapeutic areas. Read more...

Local Enrollment Specialists™

CSSi Local Enrollment SpecialistsTM increase performance at the site, making an impact for the entire program. Read more...

Mission and Vision

Mission

The mission of CSSi is to provide innovative patient enrollment and retention planning and performance designed to exceed our client's expectations. We achieve this mission by addressing the key factors in a successful patient recruitment campaign: the right strategy for the protocol and the right tools to complete enrollment on time and on budget.

 

Vision

CSSi is an advocate of patients receiving the highest quality of medical care while enrolled in a clinical trial. Our goal is to help our clients conduct efficient and quality clinical trials while reducing enrollment timelines and cost by delivering strategic solutions that utilize our expertise in developing site-specific patient recruitment plans.

The 4-1-1 on Clinical Trials

The 4-1-1 on Clinical Trials

The 4-1-1 on Clinical Trials

Clinical trials are an opportunity to gain access to new research treatments before they are widely available and to receive expert medical care at a leading healthcare facility. In an effort to improve research transparency, below are key-points to know about clinical trials and how they strengthen the validity and value of medical breakthroughs.

What are Clinical Trials?
Clinical trials are research studies that test how well new medical approaches work in the human body. Each study answers scientific questions and attempts to find better ways to prevent, screen for, diagnose, or treat a disease. Every clinical trial has a protocol or action plan, and they describe:

• What will transpire in the study
• Detailed criteria about who can participate
• How the study will be conducted
• Why the trial is necessary

Why Conduct Clinical Trials?
Clinical trials produce data for healthcare decision making and contribute invaluable information about the benefits and safety of new and existing therapies. The results for therapeutic clinical trials can provide doctors, families, and patients with new drugs and treatments.

Clinical Trial Process
A healthcare team conducts health screenings to ensure that a participant qualifies for the clinical trial.
Once a participant is eligible, instructions are provided to make certain that visits and study procedures are fulfilled for best results.
Medical vitals are carefully monitored.
Once the clinical trials are complete, the participant may contact the research team for questions.

Phases of Clinical Trials

Phase I – The experimental drug or treatment is tested in a small group of people (10-80) who are often the first to receive a new therapy or a new combination of therapies. In this phase, researchers evaluate its safety, dosage range and identify side effects.

Phase II – The experimental drug or treatment is given to a larger group of people (100-200). Researchers continue to evaluate the treatment and if it is further effective.

Phase III – The new drug or treatment that has shown promising results is used on a larger group of people (1,000 – 3,000) and compared to the current standard of care for that specific disease.

Phase IV – Post marketing studies delineate additional information including the drug’s risks, benefits, and optimal use.

Volunteering in clinical trials helps future generations advance medical research, and provides a sense of hope for the future. If you are interested in volunteering for a clinical trials, begin your search by visiting our nationwide database at www.MyClinicalTrial.com.

 

Join the CSSi Community

We're always on top of industry news, current trends and the always evolving clinical research landscape. Stay up-to-date with the latest observations, news and updates from the CSSi patient recruitment experts.

Subscribe! Learn from us! Ask questions!

Study Enrolls Three Months Ahead of Schedule when CSSi Goes the Extra Step in Special Population Recruitment

May 14, 2015

Glen Burnie, MD – CSSi, (www.CSSiEnroll.com) the leader in patient recruitment solutions for the clinical research industry, recently partnered with a major pharmaceutical company to support the recruitment and enrollment of a special population study. The overall enrollment goal was 1,200 patients using 110 sites within 12 months. The protocol required at least 15% (180) Hispanic and 20% (240) African American patients.

There were many challenges with this study, including competition for patients within this indication, lack of awareness about clinical trials, fragmented implementation of tools and tactics, need for education about the study, maintenance issues with screening activities at the site, and lack of study coordinator bandwidth to complete recruitment activities.

CSSi worked with each site to develop the most appropriate recruitment plan based on their patient population, local community demographics, and overall recruitment needs. CSSi developed a recruitment strategy for each of the different target audiences along with race specific messaging to be used with sites where the demographics were highly weighted toward the group. They utilized best practices in recruiting these special populations, including involving the investigators in the community, focusing on community-based outreach as it is a proven tactic for reaching people of Hispanic heritage.  Also, targeting African American patients with radio advertising, as it has been the most successful tactic for this population. Northern urban sites focused on African American populations while Southern sites focused on the higher density of Hispanic populations within these regions.

While targeting special populations with customized tools and tactics, CSSi contributed 634 non Hispanic/Caucasian patients representing 52 % of enrolled patients. 220 of the 180 patients who identified themselves as Hispanic were enrolled, and 346 of the required 240 African American patients were enrolled. There were high screening rates at 75% of the sites, due to custom enrollment planning, and this was the main reason for finishing the study three months early – meeting recruitment goals in nine months time. 

About CSSi 

CSSi delivers global solutions that ensure successful enrollment, on time, every time. Through its innovative enrollment planning and full-service patient recruitment solutions, CSSi is able to reduce the costs and timelines associated with recruitment of subjects for clinical studies. CSSi is the only patient recruitment company with a worldwide team of Local Enrollment Specialists™ (LES™), on the ground, close to sites and able to meet your study's recruitment goals on time.

CSSi has a commitment and passion for finding life cycle solutions to bring drugs or devices to market quickly by reducing development costs and resources. Our vision is to ensure that the best possible medicines and devices reach patients as quickly as possible.​ For more information on CSSi, visit www.CSSiEnroll.com , or contact Shannon Powell, Marketing at This email address is being protected from spambots. You need JavaScript enabled to view it. or 443-308-5809.

  •    It was a long journey, and we are all delighted at the successful outcome. We appreciate the support [the CSS] team provided along the way. Hopefully, we can work together again in the future.

    -Sponsor
  •    You have made our advertising so much easier and taken time off my plate, which is always appreciated. We look forward to a prosperous relationship ahead!

    -Investigative Site
  •    …greatly appreciate your help throughout the year. You have taken a significant burden off my shoulders over the past several years.

    -Investigative Site
  •    I cannot begin to express my appreciation for a job well done and the continued efforts you place to ensure that this study was a success! Your candor and transparency has been refreshing and I am fortunate to have partnered with such a great group of patient recruitment and retention experts! You are wonderful!

    -Top 10 CRO
  •     I wanted to take a moment and say thank you for continuing to do a great job and meeting our expectations. I could not be more pleased with the teamwork and efficiency in which you both approach (our) study!

    Top 10 CRO
  •    To begin with, please let yourteam know that everyone is doing a FANTASTIC job with compiling the information for this difficult study.

    -Top 10 CRO
  •    I would not hesitate to use CSS again! Your team has been an absolute pleasure to work with and I consider us friends as well. If you are ever in the Raleigh area, please let me know.

    -Sponsor
  •    We had the phones ringing off the hook for a few days, and we ended with approximately 60 individuals who sounded like viable screeners from the contact list. They are spread out over the next six weeks. Up to this time we have only screened about 30 others (before campaign) had 16 that were cultured and four successfully enrolled, so we are running about 11% from screen appointment to successfully enrolled! By the way, overall this is the best ad response we have ever had!

    -Dermatology Investigator
  •    If this sounds like a "paid advertisement" for CSS, it's not. I just can't say enough good things about how they have helped us grow as a site by putting our name out there in a very professional way. To me it only makes sense to use CSS or a company like them (I just think they are the best one). We are in the business of research, not advertising. Let the experts in advertising handle that job for your site and put your energy into doing what you do best…research.

    -Multi-specialty Investigative Site
  •    It is a PLEASURE working with the CSS team! I could not be more pleased with the progress thus far and feel that the communication and team oriented approach is EXACTLY what we are looking for.

    -Top 10 CRO

Offices and Locations

  • US Address:
    6958 Aviation Blvd
    Suite H
    Glen Burnie, MD 21061
    UK Address:
    20-22 Bedford Row
    London
    WC1R 4JS
    India Address:
    G-A, “Hyndava Techno Park”,
    Plot No. 12,
    Survey No. 64,
    Hitec City, Phase 2,
    Madhapur,
    Hyderabad - 500081